Multiple Myeloma: Hematology Journal Club 3.0


This journal club was a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
Speaker: Dr. Amar Lal
Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates
This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
Speaker: Ramesh Pandita
Affiliations: Consultant Hematologist/ Oncologist , KCCC , Kuwait
This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
Speaker: Husni Hateeti
Affiliations: Consultant Hematologist, SKMC - Abu Dhabi, United Arab Emirates
This presentation was part of a scientific educational activity on identification of Lenalidomide refractory Multiple Myeloma patients using the IMWG criteria and Discuss CANDOR & MMY1001 trials.
A panel discussion that included Dr. Amar Lal, Dr. Ramesh Pandita, and Dr. Husni Hateeti.